PMA Required For OvaCheck Software, FDA Tells Correlogic
This article was originally published in The Gray Sheet
Executive Summary
Correlogic plans to pull OvaCheck software from lab facilities and do the analysis in-house to avoid FDA regulation of the firm's ovarian cancer blood test